Avenue Therapeutics ATXI Cash Flow Statement (2016-2026)

OTC ATXI
$0.40 -0.03 (-6.98%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Avenue Therapeutics Quarterly Cash Flow Statement

Periods 42 quarters
Latest Jun 2026

Avenue Therapeutics reported cash from operations of -$0.47M and free cash flow of -$0.47M for the quarter ended Jun 2026, down 169.9% year over year. This cash flow statement covers 42 quarters of results from Mar 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-0.87M-0.91M-2.86M-0.60M-0.66M0.52M-7.60M-4.02M0.51M0.62M-4.35M-2.70M-3.09M-1.56M-1.86M0.33M-0.69M-0.73M-0.70M-0.69M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
Share-based CompensationStock Comp.
0.07M0.14M0.57M0.04M0.03M0.01M0.01M0.03M0.56M0.31M0.19M0.19M0.33M0.52M0.19M0.18M0.16M0.14M0.06M0.06M
Other non-cash itemsOther Non-Cash
-4.42M0.88M0.15M-2.57M-2.38M0.12M-0.26M-0.02M-0.01M-0.02M0.00M0.00M0.00M0.00M
Change in Working Capital
Change in Accured ExpensesChange Accured Exp.
0.26M-0.22M0.30M-0.35M-0.04M0.48M0.91M-0.94M0.78M-1.11M0.39M0.12M-0.17M-0.14M0.46M0.07M0.09M-0.32M0.17M0.14M
Change in Other Operating AssetsOther Assets Change
-0.04M0.08M-0.07M-0.01M-0.10M0.12M0.07M-0.12M-0.06M0.04M0.05M-0.05M-0.04M0.05M0.01M-0.06M-0.02M0.06M-0.03M-0.02M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.03M-0.13M0.08M-0.04M0.03M-0.02M
Other Working Capital ChangesOther WC Changes
0.01M-0.21M0.16M-0.03M0.13M-0.14M-0.07M0.12M0.06M-0.04M-0.05M0.05M0.04M-0.05M-0.01M0.06M0.02M-0.06M0.03M0.02M
Cash from OperationsCash from Ops.
-0.54M-1.20M-1.93M-0.94M-0.55M-4.17M-1.57M-4.67M-0.89M-2.32M-3.12M-2.25M-2.89M-0.76M-1.19M-0.18M0.38M-0.85M-0.44M-0.48M
Investing Activities
Change in IntangiblesChange Intangibless
1.00M
Sale and Maturity of InvestmentsInvestments Sold
Change in Acquisitions & DivestmentsChange Acquisitions
Cash from Investing ActivitiesCash from Investing
-1.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
0.15M0.55M-0.55M4.97M4.74M0.57M0.76M2.09M0.01M
Shares Repurchased
Net Shares Issued and RepurchasedNet Shares Issued
0.15M0.55M-0.55M4.97M4.74M0.57M0.76M2.09M0.01M
Net Equity Issued and RepurchasedNet Equity Issued
0.15M0.55M-0.55M4.97M4.74M0.57M0.76M2.09M0.01M
Other financing activitiesOther financing
-0.39M
Cash from Financing ActivitiesCash from Financing
-0.12M10.66M3.10M0.48M3.95M4.53M3.98M0.57M0.76M2.09M
Additional items
Change in Cash
-0.54M3.18M-1.93M-0.94M-0.67M6.49M1.53M-6.67M-1.41M1.62M1.41M1.73M-2.32M0.00M0.91M-0.18M0.38M-0.85M-0.44M-0.48M
Ending Cash Balance
0.59M3.76M1.83M0.89M0.22M6.71M8.24M1.57M0.16M1.78M3.19M4.92M2.60M2.59M3.50M3.33M3.71M2.86M2.42M1.94M
Free Cash FlowFCF
-0.54M-1.20M-1.93M-0.94M-0.55M-4.17M-1.57M-4.67M-0.89M-2.32M-3.12M-2.25M-2.89M-0.76M-1.19M-0.18M0.38M-0.85M-0.44M-0.48M
Net Cash FlowNCF
-0.54M-1.20M-1.93M-0.94M-0.67M6.49M1.53M-4.67M-1.41M1.62M1.41M1.73M-2.32M0.00M0.91M-0.18M0.38M-0.85M-0.44M-0.48M
Interest Paid

Avenue Therapeutics Cash Flow Statement API

Pull Avenue Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ATXI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY